Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00865_DB01247_nanopub.RA4XD03ToEhGlShDCdRHEH_XHBmKPg2KmDSwjXUd00MyY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00865_DB01247 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00865_DB01247 label "DDI between Benzphetamine and Isocarboxazid - MAO Inhibitors may enhance the hypertensive effect of Amphetamines. Concomitant use of amphetamines and monoamine oxidase inhibitors (MAOI) should be avoided. If used concomitantly, careful monitoring of blood pressure must occur. It may take up to 2 weeks after the discontinuation of an MAOI for the effects to dissipate enough to afford safety to the administration of interacting agents. [drugbank_resource:DB00865_DB01247]" assertion.
- drugbank_resource:DB00865_DB01247 identifier "drugbank_resource:DB00865_DB01247" assertion.
- drugbank_resource:DB00865_DB01247 title "DDI between Benzphetamine and Isocarboxazid - MAO Inhibitors may enhance the hypertensive effect of Amphetamines. Concomitant use of amphetamines and monoamine oxidase inhibitors (MAOI) should be avoided. If used concomitantly, careful monitoring of blood pressure must occur. It may take up to 2 weeks after the discontinuation of an MAOI for the effects to dissipate enough to afford safety to the administration of interacting agents." assertion.
- drugbank:DB01247 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00865_DB01247 assertion.
- drugbank:DB00865 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00865_DB01247 assertion.